Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The T-cell surface glycoprotein CD3 gamma chain (CD3G) is an essential transmembrane subunit of the T-cell receptor (TCR)-CD3 complex, primarily expressed on the surface of mature T lymphocytes and thymocytes (UniProt P09693; Wikipedia). It plays a pivotal role in the adaptive immune response by coupling extracellular antigen recognition to intracellular signaling pathways through its cytoplasmic immunoreceptor tyrosine-based activation motif (ITAM) (NCBI Gene 917; UniProt P09693). Beyond signal transduction, CD3G is critical for the assembly, trafficking, and stable surface expression of the TCR complex, utilizing a di-leucine-based motif to regulate receptor internalization and recycling (PubMed 8187769; Open Targets). Mutations in the CD3G gene lead to T-cell immunodeficiency (IMD17), characterized by impaired T-cell development and increased susceptibility to infections and autoimmunity (NCBI Gene 917; PubMed 25920998). While most established CD3-targeted therapies, such as Muromonab-CD3 and various bispecific antibodies, primarily engage the CD3 epsilon subunit, CD3G is increasingly recognized as a distinct therapeutic target for fine-tuning T-cell activation in autoimmune diseases and oncology (Cusabio; Creative Biogene). Its expression levels and genetic variants also serve as valuable biomarkers for monitoring immune status and predicting treatment outcomes in sepsis and cancer (PubMed 25920998; NIH).
CD3G acts as a signal transduction subunit within the TCR-CD3 complex. Upon antigen binding to the TCR, the immunoreceptor tyrosine-based activation motifs (ITAMs) in the cytoplasmic tail of CD3G are phosphorylated by Src-family kinases like Lck and Fyn (UniProt P09693; PubMed 2470098). This phosphorylation recruits ZAP-70, initiating downstream signaling cascades including the Ras-MAPK, PKC, and calcium-NFAT pathways, leading to T-cell activation and proliferation (Creative Biogene; PubMed 25920998). Additionally, CD3G regulates TCR expression levels through a di-leucine-based sorting motif that mediates constitutive receptor internalization and recycling (UniProt P09693; PubMed 8187769).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell surface glycoprotein CD3 gamma chain (CD3G) (CD3G).